BioTech Firm Wants Redo In $7.5M IP Fight At Fed Circ.
Law360 (May 21, 2019, 9:32 PM EDT) -- Biotechnology company Novozymes A/S has told the Federal Circuit it can't be liable for infringing ethanol processing patents because a previous invention clearly anticipated the patented technology, and it asked the full court to reject a $7.5 million jury verdict.
Novozymes said in a motion for rehearing Monday that a prior international patent application, referred to as the Veit application, showed how to reduce an acid that can cause problems for ethanol processing equipment. Although the Veit application didn't discuss the result of the acid's reduction, the benefit of that process was still anticipated in that filing, Novozymes said.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!